{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:53:36Z","timestamp":1782849216021,"version":"3.54.5"},"reference-count":49,"publisher":"Pleiades Publishing Ltd","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochemistry Moscow"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>\n                      The mechanisms underlying the recently discovered catalase activity of immunoglobulin\u00a0G (IgG) in patients with schizophrenia remain unclear. Using a series of rigorous criteria, it has been demonstrated that this activity is an intrinsic property of antibodies themselves. The\u00a0present study shows that classical catalase inhibitors also suppress the catalase activity of\u00a0IgG. Specifically, inhibitor analysis revealed a dose-dependent reduction in the IgG catalase activity following addition of sodium azide (IC\n                      <jats:sub>50<\/jats:sub>\n                      \u00a0=\u00a0140\u00a0\u03bcM) and 3-aminotriazole (IC\n                      <jats:sub>50<\/jats:sub>\n                      \u00a0=\u00a016.06\u00a0\u03bcM), suggesting that the catalytic mechanism of IgG shares similarities with that of classical catalase and may be due to the ability of antibodies to bind metalloporphyrin complexes, including heme. IgG catalase activity in patients with schizophrenia during therapeutic remission was significantly reduced, being fourfold lower than in healthy controls (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.0004) and twofold lower than in patients during disease exacerbation (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.002). A moderate positive correlation was observed between the total Positive and Negative Syndrome Scale (PANSS) score and IgG catalase activity (R\u00a0=\u00a00.32,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.01). Therefore, IgG catalase activity in patients with schizophrenia depends on the disease clinical state and may contribute to the regulation of reactive oxygen species (ROS) metabolism and the severity of oxidative stress in affected individuals.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1134\/s0006297926600456","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:09:16Z","timestamp":1782846556000},"page":"1023-1033","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hydrogen Peroxide Dismutation by Immunoglobulins G from Patients with Schizophrenia"],"prefix":"10.1134","volume":"91","author":[{"given":"Daria V.","family":"Kazantseva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liudmila P.","family":"Smirnova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena G.","family":"Kornetova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana A.","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"137","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"3053_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2025.1629032","volume":"16","author":"Z. Zhan","year":"2025","unstructured":"Zhan, Z., Wang, J., and Shen, T. (2025) Results of the Global Burden of Disease study for schizophrenia: trends from 1990 to 2021 and projections to 2050, Front. Psychiatry, 16, 1629032, \nhttps:\/\/doi.org\/10.3389\/fpsyt.2025.1629032.","journal-title":"Front. Psychiatry"},{"key":"3053_CR2","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.1038\/s41380-023-02138-4","volume":"28","author":"M. Solmi","year":"2023","unstructured":"Solmi, M., Seitidis, G., Mavridis, D., Correll, C. U., Dragioti, E., Guimond, S., Tuominen, L., Darg\u00e9l, A., Carvalho, A. F., Fornaro, M., Maes, M., Monaco, F., Song, M., Il Shin, J., and Cortese, S. (2023) Incidence, prevalence, and global burden of schizophrenia \u2013 data, with critical appraisal, from the Global Burden of Disease (GBD) 2019, Mol. Psychiatry, 28, 5319-5327, \nhttps:\/\/doi.org\/10.1038\/s41380-023-02138-4.","journal-title":"Mol. Psychiatry"},{"key":"3053_CR3","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8881770","volume":"2021","author":"E. A. Ermakov","year":"2021","unstructured":"Ermakov, E. A., Dmitrieva, E. M., Parshukova, D. A., Kazantseva, D. V., Vasilieva, A. R., and Smirnova, L. P. (2021) Oxidative stress-related mechanisms in schizophrenia pathogenesis and new treatment perspectives, Oxid. Med. Cell Longev., 2021, 8881770, \nhttps:\/\/doi.org\/10.1155\/2021\/8881770.","journal-title":"Oxid. Med. Cell Longev."},{"key":"3053_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2022.114429","volume":"309","author":"X. X. Goh","year":"2022","unstructured":"Goh, X. X., Tang, P. Y., and Tee, S. F. (2022) Effects of antipsychotics on antioxidant defence system in patients with schizophrenia: a meta-analysis, Psychiatry Res., 309, 114429, \nhttps:\/\/doi.org\/10.1016\/j.psychres.2022.114429.","journal-title":"Psychiatry Res."},{"key":"3053_CR5","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","volume":"86","author":"H. Sies","year":"2017","unstructured":"Sies, H., Berndt, C., and Jones, D. P. (2017) Oxidative stress, Annu. Rev. Biochem., 86, 715-748, \nhttps:\/\/doi.org\/10.1146\/annurev-biochem-061516-045037.","journal-title":"Annu. Rev. Biochem."},{"key":"3053_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13030312","volume":"13","author":"Y. Hong","year":"2024","unstructured":"Hong, Y., Boiti, A., Vallone, D., and Foulkes, N. S. (2024) Reactive oxygen species signaling and oxidative stress: transcriptional regulation and evolution, Antioxidants (Basel), 13, 312, \nhttps:\/\/doi.org\/10.3390\/antiox13030312.","journal-title":"Antioxidants (Basel)"},{"key":"3053_CR7","first-page":"58","volume":"1","author":"I. V. Kondakova","year":"2005","unstructured":"Kondakova, I. V., Kakurina, G. V., Smirnova, L. P., and Borunov, E. V. (2005) Regulation of proliferation and apoptosis of tumor cells by free radicals [in Russian], Sib. Oncol.\u00a0J., 1, 58-61.","journal-title":"Sib. Oncol.\u00a0J."},{"key":"3053_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12081623","volume":"12","author":"M. Roginskaya","year":"2023","unstructured":"Roginskaya, M., and Razskazovskiy, Y. (2023) Oxidative DNA damage and repair: mechanisms, mutations, and relation to diseases, Antioxidants (Basel), 12, 1623, \nhttps:\/\/doi.org\/10.3390\/antiox12081623.","journal-title":"Antioxidants (Basel)"},{"key":"3053_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/10715762.2020.1851027","volume":"55","author":"M. Akagawa","year":"2021","unstructured":"Akagawa, M. (2021) Protein carbonylation: molecular mechanisms, biological implications, and analytical approaches, Free Radic. Res., 55, 307-320, \nhttps:\/\/doi.org\/10.1080\/10715762.2020.1851027.","journal-title":"Free Radic. Res."},{"key":"3053_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/antiox7070093","volume":"7","author":"C. A. Gallelli","year":"2018","unstructured":"Gallelli, C. A., Calcagnini, S., Romano, A., Koczwara, J. B., de Ceglia, M., Dante, D., Villani, R., Giudetti, A. M., Cassano, T., and Gaetani, S. (2018) Modulation of the oxidative stress and lipid peroxidation by endocannabinoids and their lipid analogues, Antioxidants (Basel), 7, 93, \nhttps:\/\/doi.org\/10.3390\/antiox7070093.","journal-title":"Antioxidants (Basel)"},{"key":"3053_CR11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2305035121","volume":"121","author":"J. Gustafsson","year":"2024","unstructured":"Gustafsson, J., Robinson, J. L., Zetterberg, H., and Nielsen, J. (2024) Brain energy metabolism is optimized to minimize the cost of enzyme synthesis and transport, Proc. Natl. Acad. Sci. USA, 121, e2305035121, \nhttps:\/\/doi.org\/10.1073\/pnas.2305035121.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"3053_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2023.109555","volume":"737","author":"K. Stachowicz","year":"2023","unstructured":"Stachowicz, K. (2023) The role of polyunsaturated fatty acids in neuronal signaling in depression and cognitive processes, Arch. Biochem. Biophys., 737, 109555, \nhttps:\/\/doi.org\/10.1016\/j.abb.2023.109555.","journal-title":"Arch. Biochem. Biophys."},{"key":"3053_CR13","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s00775-019-01731-9","volume":"24","author":"K. Acevedo","year":"2019","unstructured":"Acevedo, K., Masaldan, S., Opazo, C. M., and Bush, A. I. (2019) Redox active metals in neurodegenerative diseases, J.\u00a0Biol. Inorg. Chem., 24, 1141-1157, \nhttps:\/\/doi.org\/10.1007\/s00775-019-01731-9.","journal-title":"J.\u00a0Biol. Inorg. Chem."},{"key":"3053_CR14","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/j.bbadis.2018.11.007","volume":"1865","author":"P. Pic\u00f3n-Pag\u00e8s","year":"2019","unstructured":"Pic\u00f3n-Pag\u00e8s, P., Garcia-Buendia, J., and Mu\u00f1oz, F. J. (2019) Functions and dysfunctions of nitric oxide in brain, Biochim. Biophys. Acta Mol. Basis Dis., 1865, 1949-1967, \nhttps:\/\/doi.org\/10.1016\/j.bbadis.2018.11.007.","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"3053_CR15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s10863-009-9257-z","volume":"41","author":"T. G. Hastings","year":"2009","unstructured":"Hastings, T. G. (2009) The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease, J. Bioenerg. Biomembr., 41, 469-472, \nhttps:\/\/doi.org\/10.1007\/s10863-009-9257-z.","journal-title":"J. Bioenerg. Biomembr."},{"key":"3053_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2025.1604378","volume":"17","author":"K. Zhang","year":"2025","unstructured":"Zhang, K., Wen, M., Nan, X., Zhao, S., Li, H., Ai, Y., and Zhu, H. (2025) NMDA receptors in neurodegenerative diseases: mechanisms and emerging therapeutic strategies, Front. Aging Neurosci., 17, 1604378, \nhttps:\/\/doi.org\/10.3389\/fnagi.2025.1604378.","journal-title":"Front. Aging Neurosci."},{"key":"3053_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10715762.2019.1702656","volume":"54","author":"G. B. N. Chainy","year":"2020","unstructured":"Chainy, G. B. N., and Sahoo, D. K. (2020) Hormones and oxidative stress: an overview, Free Radic. Res., 54, 1-26, \nhttps:\/\/doi.org\/10.1080\/10715762.2019.1702656.","journal-title":"Free Radic. Res."},{"key":"3053_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11101870","volume":"11","author":"V. Rambaud","year":"2022","unstructured":"Rambaud, V., Marzo, A., and Chaumette, B. (2022) Oxidative stress and emergence of psychosis, Antioxidants, 11, 1870, \nhttps:\/\/doi.org\/10.3390\/antiox11101870.","journal-title":"Antioxidants"},{"key":"3053_CR19","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s12031-018-1165-4","volume":"66","author":"Z. L. Bai","year":"2018","unstructured":"Bai, Z. L., Li, X. S., Chen, G. Y., Du, Y., Wei, Z. X., Chen, X., Zheng, G. E., Deng, W., and Cheng, Y. (2018) Serum oxidative stress marker levels in unmedicated and medicated patients with schizophrenia, J.\u00a0Mol. Neurosci., 66, 428-436, \nhttps:\/\/doi.org\/10.1007\/s12031-018-1165-4.","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"3053_CR20","first-page":"58","volume":"1","author":"N. M. Krotenko","year":"2010","unstructured":"Krotenko, N. M., Smirnova, L. P., Loginov, V. N., Ivanova, A. S., and Semke, A. V. (2010) Effect of neuroleptic therapy on the state of lipid peroxidation and the glutathione system in patients with schizophrenia [in Russian], Sib. Herald Psychiatry Narcol., 1, 58-61.","journal-title":"Sib. Herald Psychiatry Narcol."},{"key":"3053_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s10517-015-3151-y","volume":"160","author":"S. A. Ivanova","year":"2015","unstructured":"Ivanova, S. A., Smirnova, L. P., Shchigoreva, Y. G., Semke, A. V., and Bokhan, N. A. (2015) Serum glutathione in patients with schizophrenia in dynamics of antipsychotic therapy, Bull. Exp. Biol. Med., 160, 283-285, \nhttps:\/\/doi.org\/10.1007\/s10517-015-3151-y.","journal-title":"Bull. Exp. Biol. Med."},{"key":"3053_CR22","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.schres.2005.10.011","volume":"81","author":"X. Y. Zhang","year":"2006","unstructured":"Zhang, X. Y., Tan, Y. L., Cao, L. Y., Wu, G. Y., Xu, Q., Shen, Y., and Zhou, D. F. (2006) Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics, Schizophr. Res., 81, 291-300, \nhttps:\/\/doi.org\/10.1016\/j.schres.2005.10.011.","journal-title":"Schizophr. Res."},{"key":"3053_CR23","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.autrev.2012.10.009","volume":"12","author":"A. Mahendra","year":"2013","unstructured":"Mahendra, A., Sharma, M., Rao, D. N., Peyron, I., Planchais, C., Dimitrov, J. D., Kaveri, S. V., and Lacroix-Desmazes, S. (2013) Antibody-mediated catalysis: induction and therapeutic relevance, Autoimmun. Rev., 12, 648-652, \nhttps:\/\/doi.org\/10.1016\/j.autrev.2012.10.009.","journal-title":"Autoimmun. Rev."},{"key":"3053_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183867","volume":"12","author":"E. A. Ermakov","year":"2017","unstructured":"Ermakov, E. A., Smirnova, L. P., Bokhan, N. A., Semke, A. V., Ivanova, S. A., Buneva, V. N., and Nevinsky, G. A. (2017) Catalase activity of IgG antibodies from the sera of healthy donors and patients with schizophrenia, PLoS One, 12, e0183867, \nhttps:\/\/doi.org\/10.1371\/journal.pone.0183867.","journal-title":"PLoS One"},{"key":"3053_CR25","doi-asserted-by":"publisher","first-page":"242","DOI":"10.31857\/S102872210006588-1","volume":"13","author":"E. A. Ermakov","year":"2019","unstructured":"Ermakov, E. A., Smirnova, L. P., Krotenko, N. M., Semke, A. V., Buneva, V. N., and Nevinsky, G. A. (2019) Catalase activity of catalytic antibodies in schizophrenia [in Russian], Russ. J. Immunol., 13, 242-244, \nhttps:\/\/doi.org\/10.31857\/S102872210006588-1.","journal-title":"Russ. J. Immunol."},{"key":"3053_CR26","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/jmr.2474","volume":"28","author":"A. S. Tolmacheva","year":"2015","unstructured":"Tolmacheva, A. S., Blinova, E. A., Ermakov, E. A., Buneva, V. N., Vasilenko, N. L., and Nevinsky, G. A. (2015) IgG abzymes with peroxidase and oxidoreductase activities from the sera of healthy humans, J. Mol. Recognit., 28, 565-580, \nhttps:\/\/doi.org\/10.1002\/jmr.2474.","journal-title":"J. Mol. Recognit."},{"key":"3053_CR27","doi-asserted-by":"publisher","DOI":"10.1098\/rsos.171097","volume":"5","author":"A. S. Tolmacheva","year":"2018","unstructured":"Tolmacheva, A. S., Ermakov, E. A., Buneva, V. N., and Nevinsky, G. A. (2018) Substrate specificity of healthy human sera IgG antibodies with peroxidase and oxydoreductase activities, R. Soc. Open Sci., 5, 171097, \nhttps:\/\/doi.org\/10.1098\/rsos.171097.","journal-title":"R. Soc. Open Sci."},{"key":"3053_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8171020","volume":"2020","author":"L. P. Smirnova","year":"2020","unstructured":"Smirnova, L. P., Mednova, I. A., Krotenko, N. M., Alifirova, V. M., and Ivanova, S. A. (2020) IgG-dependent dismutation of superoxide in patients with different types of multiple sclerosis and healthy subjects, Oxid. Med. Cell Longev., 2020, 8171020, \nhttps:\/\/doi.org\/10.1155\/2020\/8171020.","journal-title":"Oxid. Med. Cell Longev."},{"key":"3053_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12091449","volume":"12","author":"I. A. Mednova","year":"2022","unstructured":"Mednova, I. A., Smirnova, L. P., Vasilieva, A. R., Kazantseva, D. V., Epimakhova, E. V., Krotenko, N. M., Semke, A. V., and Ivanova, S. A. (2022) Immunoglobulins G of patients with schizophrenia protects from superoxide: pilot results, J. Pers Med., 12, 1449, \nhttps:\/\/doi.org\/10.3390\/jpm12091449.","journal-title":"J. Pers Med."},{"key":"3053_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2017.00083","volume":"8","author":"S. Najjar","year":"2017","unstructured":"Najjar, S., Pahlajani, S., De Sanctis, V., Stern, J. N. H., Najjar, A., and Chong, D. (2017) Neurovascular unit dysfunction and blood\u2013brain barrier hyperpermeability contribute to schizophrenia neurobiology: a theoretical integration of clinical and experimental evidence, Front. Psychiatry, 8, 83, \nhttps:\/\/doi.org\/10.3389\/fpsyt.2017.00083.","journal-title":"Front. Psychiatry"},{"key":"3053_CR31","doi-asserted-by":"publisher","first-page":"26696","DOI":"10.1074\/jbc.M702751200","volume":"282","author":"J. D. Dimitrov","year":"2007","unstructured":"Dimitrov, J. D., Roumenina, L. T., Doltchinkova, V.\u00a0R., Mihaylova, N.\u00a0M., Lacroix-Desmazes, S., Kaveri, S. V., and Vassilev, T.\u00a0L. (2007) Antibodies use heme as a cofactor to extend their pathogen elimination activity and to acquire new effector functions, J.\u00a0Biol. Chem., 282, 26696-26706, \nhttps:\/\/doi.org\/10.1074\/jbc.M702751200.","journal-title":"J.\u00a0Biol. Chem."},{"key":"3053_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-021-01931-7","volume":"4","author":"M. Lecerf","year":"2021","unstructured":"Lecerf, M., Kanyavuz, A., Rossini, S., and Dimitrov, J. D. (2021) Interaction of clinical-stage antibodies with heme predicts their physiochemical and binding qualities, Commun. Biol., 4, 391, \nhttps:\/\/doi.org\/10.1038\/s42003-021-01931-7.","journal-title":"Commun. Biol."},{"key":"3053_CR33","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1074\/jbc.M509190200","volume":"281","author":"J. D. Dimitrov","year":"2006","unstructured":"Dimitrov, J. D., Ivanovska, N. D., Lacroix-Desmazes, S., Doltchinkova, V. R., Kaveri, S. V., and Vassilev, T. L. (2006) Ferrous ions and reactive oxygen species increase antigen-binding and anti-inflammatory activities of immunoglobulin G, J.\u00a0Biol. Chem., 281, 439-446, \nhttps:\/\/doi.org\/10.1074\/jbc.M509190200.","journal-title":"J.\u00a0Biol. Chem."},{"key":"3053_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/jimmun\/vkaf015","volume":"214","author":"R. V. Lacombe","year":"2025","unstructured":"Lacombe, R. V., Lorin, V., Planchais, C., Lassouani, T. H., Haerens, E., Lecerf, M., Lacroix-Desmazes, S., Mouquet, H., and Dimitrov, J. D. (2025) HIV-1 broadly neutralizing antibodies demonstrate a high propensity for binding to heme, J.\u00a0Immunol., 214, 1370, \nhttps:\/\/doi.org\/10.1093\/jimmun\/vkaf015.","journal-title":"J.\u00a0Immunol."},{"key":"3053_CR35","first-page":"1245","volume":"65","author":"G. A. Nevinsky","year":"2000","unstructured":"Nevinsky, G. A., Kanyshkova, T. G., and Buneva, V. N. (2000) Natural catalytic antibodies (abzymes) in normalcy and pathology, Biochemistry (Moscow), 65, 1245-1255.","journal-title":"Biochemistry (Moscow)"},{"key":"3053_CR36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3233\/NIB-2012-012042","volume":"3","author":"G. A. Nevinsky","year":"2012","unstructured":"Nevinsky, G. A., and Buneva, V. N. (2012) Autoantibodies and natural catalytic antibodies in health, multiple sclerosis, and some other diseases, Adv. Neuroimm. Biol., 3, 157-182, \nhttps:\/\/doi.org\/10.3233\/NIB-2012-012042.","journal-title":"Adv. Neuroimm. Biol."},{"key":"3053_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.703452","volume":"12","author":"A. J. Murray","year":"2021","unstructured":"Murray, A. J., Rogers, J. C., Katshu, M. Z. U. H., Liddle, P. F., and Upthegrove, R. (2021) Oxidative stress and the pathophysiology and symptom profile of schizophrenia spectrum disorders, Front. Psychiatry, 12, 703452, \nhttps:\/\/doi.org\/10.3389\/fpsyt.2021.703452.","journal-title":"Front. Psychiatry"},{"key":"3053_CR38","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/ijnp\/pyx015","volume":"20","author":"D. Fraguas","year":"2017","unstructured":"Fraguas, D., D\u00edaz-Caneja, C. M., Rodr\u00edguez-Quiroga, A., and Arango, C. (2017) Oxidative stress and inflammation in early onset first episode psychosis: a systematic review and meta-analysis, Int. J. Neuropsychopharmacol., 20, 435-444, \nhttps:\/\/doi.org\/10.1093\/ijnp\/pyx015.","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"3053_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073898","volume":"23","author":"A. S. Tolmacheva","year":"2022","unstructured":"Tolmacheva, A. S., and Nevinsky, G. A. (2022) Essential protective role of catalytically active antibodies (abzymes) with redox antioxidant functions in animals and humans, Int. J. Mol. Sci., 23, 3898, \nhttps:\/\/doi.org\/10.3390\/ijms23073898.","journal-title":"Int. J. Mol. Sci."},{"key":"3053_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.schres.2014.02.005","volume":"154","author":"L. De Witte","year":"2014","unstructured":"De Witte, L., Tomasik, J., Schwarz, E., Guest, P. C., Rahmoune, H., Kahn, R. S., and Bahn, S. (2014) Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment, Schizophr. Res., 154, 23-29, \nhttps:\/\/doi.org\/10.1016\/j.schres.2014.02.005.","journal-title":"Schizophr. Res."},{"key":"3053_CR41","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s11427-010-0013-8","volume":"53","author":"M. Zhang","year":"2010","unstructured":"Zhang, M., Zhao, Z., He, L., and Wan, C. (2010) A meta-analysis of oxidative stress markers in schizophrenia, Sci. China Life Sci., 53, 112-124, \nhttps:\/\/doi.org\/10.1007\/s11427-010-0013-8.","journal-title":"Sci. China Life Sci."},{"key":"3053_CR42","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1089\/ars.2010.3603","volume":"15","author":"J. K. Yao","year":"2011","unstructured":"Yao, J. K., and Keshavan, M. S. (2011) Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view, Antioxid. Redox Signal., 15, 2011-2035, \nhttps:\/\/doi.org\/10.1089\/ars.2010.3603.","journal-title":"Antioxid. Redox Signal."},{"key":"3053_CR43","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.schres.2016.07.010","volume":"176","author":"I. Sadowska-Bartosz","year":"2016","unstructured":"Sadowska-Bartosz, I., Galiniak, S., Bartosz, G., Zuberek, M., Grzelak, A., and Dietrich-Muszalska, A. (2016) Antioxidant properties of atypical antipsychotic drugs used in the treatment of schizophrenia, Schizophr. Res., 176, 245-251, \nhttps:\/\/doi.org\/10.1016\/j.schres.2016.07.010.","journal-title":"Schizophr. Res."},{"key":"3053_CR44","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.biopha.2016.02.047","volume":"81","author":"F. F. Brinholi","year":"2016","unstructured":"Brinholi, F. F., Farias, C. C., Bonif\u00e1cio, K. L., Higachi, L., Casagrande, R., Moreira, E. G., and Barbosa, D. S. (2016) Clozapine and olanzapine are better antioxidants than haloperidol, quetiapine, risperidone and ziprasidone in in vitro models, Biomed. Pharmacother., 81, 411-415, \nhttps:\/\/doi.org\/10.1016\/j.biopha.2016.02.047.","journal-title":"Biomed. Pharmacother."},{"key":"3053_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58101491","volume":"58","author":"V. V. Djordjevi\u0107","year":"2022","unstructured":"Djordjevi\u0107, V. V., Kosti\u0107, J., Krivokapi\u0107, \u017d., Krtini\u0107, D., Rankovi\u0107, M., Petkovi\u0107, M., and \u0106osi\u0107, V. (2022) Decreased activity of erythrocyte catalase and glutathione peroxidase in patients with schizophrenia, Medicina (Kaunas), 58, 1491, \nhttps:\/\/doi.org\/10.3390\/medicina58101491.","journal-title":"Medicina (Kaunas)"},{"key":"3053_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13030490","volume":"13","author":"M. Wi\u0119d\u0142ocha","year":"2023","unstructured":"Wi\u0119d\u0142ocha, M., Zborowska, N., Marcinowicz, P., D\u0119bowska, W., D\u0119bowska, M., Zalewska, A., Maciejczyk, M., Waszkiewicz, N., and Szulc, A. (2023) Oxidative stress biomarkers among schizophrenia inpatients, Brain Sci., 13, 490, \nhttps:\/\/doi.org\/10.3390\/brainsci13030490.","journal-title":"Brain Sci."},{"key":"3053_CR47","doi-asserted-by":"publisher","unstructured":"Zaksas, N. P., and Nevinsky, G. A. (2018) Minor and Trace Elements in Whole Blood, Tissues, Proteins and Immunoglobulins of Mammals, in Trace Elements-Human Health and Environment, \nhttps:\/\/doi.org\/10.5772\/intechopen.75939.","DOI":"10.5772\/intechopen.75939"},{"key":"3053_CR48","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1006\/bbrc.1995.2044","volume":"212","author":"M. Sugumaran","year":"1995","unstructured":"Sugumaran, M. (1995) A caution about the azide inhibition of enzymes associated with electrophilic metabolites, Biochem. Biophys. Res. Commun., 212, 834-839, \nhttps:\/\/doi.org\/10.1006\/bbrc.1995.2044.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"3053_CR49","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1098\/rspb.1936.0056","volume":"121","author":"D. Keilin","year":"1936","unstructured":"Keilin, D., and Hartree, E. F. (1936) The action of sodium azide on cellular respiration and on some enzymes, Proc. R. Soc. B, 121, 439-453, \nhttps:\/\/doi.org\/10.1098\/rspb.1936.0056.","journal-title":"Proc. R. Soc. B"}],"container-title":["Biochemistry (Moscow)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297926600456.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S0006297926600456","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297926600456.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:09:17Z","timestamp":1782846557000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S0006297926600456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["3053"],"URL":"https:\/\/doi.org\/10.1134\/s0006297926600456","relation":{},"ISSN":["0006-2979","1608-3040"],"issn-type":[{"value":"0006-2979","type":"print"},{"value":"1608-3040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"19 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval and consent to participate.\n                      The study was conducted in compliance with the principles of the Helsinki Declaration of the World Medical Association and was approved by the Local Ethics Committee of the Mental Health Research Institute (protocol no.\u00a0157; November\u00a018, 2022; no.\u00a0157\/1.2022). All participants provided written informed consent to participate in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"Conflict of interest.\n                      The authors of this work declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}]}}